Stock Track | Alphatec Soars on Record Q3 Revenue and Raised 2024 Outlook

Stock Track10-31

Alphatec Holdings Inc. (NASDAQ: ATEC), a leading medical technology company focused on spinal disorder treatments, saw its stock price surge by 15.3% in after-hours trading on October 30, 2024, following the company's impressive third-quarter financial results and raised full-year guidance.

For the quarter ended September 30, 2024, Alphatec reported record revenue of $151 million, surpassing analyst expectations of $147.2 million. The company's surgical revenue grew by a remarkable 30% year-over-year, driving the overall 27% increase in total revenue. Additionally, Alphatec achieved a 19% growth in new surgeon adoption, a key leading indicator of future growth potential.

Buoyed by the strong quarterly performance, Alphatec raised its full-year 2024 revenue guidance to $605 million, representing a 25% increase compared to the previous year. The company also increased its full-year adjusted EBITDA guidance to $27 million, up from the previous expectation of $25.5 million, reflecting its commitment to expanding profitability and improving cash flow.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1129360366?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-31 13:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1129360366","market":"us","top_or_hot":-1,"title":"Stock Track | Alphatec Soars on Record Q3 Revenue and Raised 2024 Outlook","media":"Stock Track","content":"<p>Alphatec Holdings Inc. (NASDAQ: ATEC), a leading medical technology company focused on spinal disorder treatments, saw its stock price surge by 15.3% in after-hours trading on October 30, 2024, following the company's impressive third-quarter financial results and raised full-year guidance.</p>\n\n<p>For the quarter ended September 30, 2024, Alphatec reported record revenue of $151 million, surpassing analyst expectations of $147.2 million. The company's surgical revenue grew by a remarkable 30% year-over-year, driving the overall 27% increase in total revenue. Additionally, Alphatec achieved a 19% growth in new surgeon adoption, a key leading indicator of future growth potential.</p>\n\n<p>Buoyed by the strong quarterly performance, Alphatec raised its full-year 2024 revenue guidance to $605 million, representing a 25% increase compared to the previous year. The company also increased its full-year adjusted EBITDA guidance to $27 million, up from the previous expectation of $25.5 million, reflecting its commitment to expanding profitability and improving cash flow.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alphatec Soars on Record Q3 Revenue and Raised 2024 Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alphatec Soars on Record Q3 Revenue and Raised 2024 Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n2024-10-31 13:51 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Alphatec Holdings Inc. (NASDAQ: ATEC), a leading medical technology company focused on spinal disorder treatments, saw its stock price surge by 15.3% in after-hours trading on October 30, 2024, ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ATEC","symbol_name":"阿尔法泰克","start_time":0,"source_url":"","article_id":"1129360366","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1129360366","pubTimestamp":1730353872,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alphatec Holdings Inc. , a leading medical technology company focused on spinal disorder treatments, saw its stock price surge by 15.3% in after-hours trading on October 30, 2024, following the company's impressive third-quarter financial results and raised full-year guidance.For the quarter ended September 30, 2024, Alphatec reported record revenue of $151 million, surpassing analyst expectations of $147.2 million. The company's surgical revenue grew by a remarkable 30% year-over-year, driving ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ATEC":"阿尔法泰克"},"translate_title":"股票赛道Alphatec第三季度收入创纪录飙升并上调2024年展望","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ATEC":1},"content_text":"Alphatec Holdings Inc. (NASDAQ: ATEC), a leading medical technology company focused on spinal disorder treatments, saw its stock price surge by 15.3% in after-hours trading on October 30, 2024, following the company's impressive third-quarter financial results and raised full-year guidance.\nFor the quarter ended September 30, 2024, Alphatec reported record revenue of $151 million, surpassing analyst expectations of $147.2 million. The company's surgical revenue grew by a remarkable 30% year-over-year, driving the overall 27% increase in total revenue. Additionally, Alphatec achieved a 19% growth in new surgeon adoption, a key leading indicator of future growth potential.\nBuoyed by the strong quarterly performance, Alphatec raised its full-year 2024 revenue guidance to $605 million, representing a 25% increase compared to the previous year. The company also increased its full-year adjusted EBITDA guidance to $27 million, up from the previous expectation of $25.5 million, reflecting its commitment to expanding profitability and improving cash flow.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1129360366"}